Mortality predictors in a cohort of patients with COVID-19 admitted to a large tertiary hospital in the city of São Paulo, Brazil

Authors

Keywords:

SARS-CoV-2, COVID-19, Mortality, Hospitalization, Prognosis

Abstract

BACKGROUND: There is discrepant information across countries regarding the natural history of patients admitted to hospitals with coronavirus disease (COVID-19), in addition to a lack of data on the scenario in Brazil. OBJECTIVE: To determine the mortality predictors in COVID-19 patients admitted to a tertiary hospital in São Paulo, Brazil. DESIGN AND SETTING: A retrospective analysis of medical records of COVID-19 patients admitted to the Hospital Central da Irmandade da Santa Casa de Misericórdia of São Paulo. METHODS: Overall, 316 patients with laboratory-confirmed COVID-19 between March 1, 2020, and July 31, 2020, were included. The analysis included the baseline characteristics, clinical progression, and outcomes. RESULTS: The mortality rate of the sample was 51.27%. Age ≥ 60 years was determined as a risk factor after multivariate logistic regression analysis. Patients with an oxygen (O2) saturation ≤ 94% upon admission accounted for 87% of the deaths (P < 0.001). Vasoactive drugs were used in 92% (P < 0.001) of patients who progressed to death, and mechanical ventilation was employed in 88% (P < 0.001) of such patients. However, patients who received corticosteroids concomitantly with mechanical ventilation had a better prognosis than those who did not. The progressive degree of pulmonary involvement observed on chest computed tomography was correlated with a worse prognosis. The presence of thrombocytopenia has been considered as a risk factor for mortality. CONCLUSION: The main predictors of in-hospital mortality after logistic regression analysis were age, O2 saturation ≤ 94% upon admission, use of vasoactive drugs, and presence of thrombocytopenia.

Downloads

Download data is not yet available.

Author Biographies

Regina Maria Alexandre Fernandes de Oliveira, Irmandade da Santa Casa de Misericórdia de São Paulo

Undergraduate Medicine Student, School of Medical Sciences, Santa Casa de São Paulo, São Paulo (SP), Brazil.

Milton Luiz Gorzoni, Irmandade da Santa Casa de Misericórdia de São Paulo

MD, PhD. Associate Professor, Department of Internal Medicine, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo (SP), Brazil.

Ronaldo Fernandes Rosa, Irmandade da Santa Casa de Misericórdia de São Paulo

MD, MSc. Instructor Professor, Department of Internal Medicine, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo (SP), Brazil.

References

World Health Organization. Pneumonia of unknown cause – China. COVID-19 - China. Available from: https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/. Accessed in 2022 (Jun 13).

World Health Organization. WHO Statement regarding cluster of pneumonia cases in Wuhan, China. Available from: https://www.who.int/china/news/detail/09-01-2020-who-statement-regarding-cluster-of-pneumonia-cases-in-wuhan-china. Accessed in 2022 (Jun 13).

World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19. Available from: https://www.who. int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed in 2022 (Jun 13).

Pollard CA, Morran MP, Nestor-Kalinoski AL. The COVID-19 pandemic: a global health crisis. Physiol Genomics. 2020;52(11):549-57. PMID: 32991251; https://doi.org/10.1152/physiolgenomics.00089.2020.

Gautret P, Million M, Jarrot PA, et al. Natural history of COVID-19 and therapeutic options. Expert Rev Clin Immunol. 2020;16(12):1159-84. PMID: 33356661; https://doi.org/10.1080/1744666X.2021.1847640.

World Health Organization. Coronavirus disease (COVID-19). Situation report - 193. 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200731-covid-19-sitrep-193.pdf?sfvrsn=42a0221d_4. Accessed in 2022 (Jun 13).

Brasil. Ministério da Saúde. Diretrizes Estratégicas. Available from: https://bvsms.saude.gov.br/bvs/pacsaude/diretrizes.php. Accessed in 2022 (Jun 22).

World Health Organization. COVID-19 clinical management: living guidance, 25 January 2021. Available from: https://apps.who.int/iris/handle/10665/338882.Accessed in 2022 (Jun 13).

World Health Organization. Active ageing - A policy framework. Geneva: World Health Organization; 2002. Available from: https://apps.who.int/iris/bitstream/handle/10665/67215/WHO_NMH_NPH_02.8.pdf?sequence=1&isAllowed=y. Accessed in 2022 (Jun 13).

World Health Organization. ICD-10: International statistical classification of diseases and related health problems: tenth revision [Internet]. 2nd ed. Geneva: World Health Organization; 2004. Available from: https://apps.who.int/iris/bitstream/handle/10665/42980/9241546530_eng.pdf?sequence=1&isAllowed=y. Accessed in 2022 (Jun 13).

Pastore CA, Pinho JA, Pinho C, et al. III Diretrizes da Sociedade Brasileira De Cardiologia sobre análise e emissão de laudos eletrocardiográficos. Arq Bras Cardiol. 2016;106(4 Supl.1):1-23. PMID: 27096665; https://doi.org/10.5935/abc.20160054.

Agarwal A, Rochwerg B, Lamontagne F, et al. A living WHO guideline on drugs for covid-19. BMJ. 2020;370:m3379. Update in: BMJ. 2020;371:m4475. Update in: BMJ. 2021;372:n860. Update in: BMJ. 2021;374:n1703. Update in: BMJ. 2021;374:n2219. Erratum in: BMJ. 2022;377:o1045. PMID: 32887691; https://doi.org/10.1136/bmj.m3379.

Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052-9. Erratum in: JAMA. 2020;323(20):2098. PMID: 32320003; https://doi.org/10.1001/jama.2020.6775.

Bellan M, Patti G, Hayden E, et al. Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients. Sci Rep. 2020;10(1):20731. PMID: 33244144; https://doi.org/10.1038/s41598-020-77698-4.

Santos MM, Lucena EES, Lima KC, et al. Survival and predictors of deaths of patients hospitalised due to COVID-19 from a retrospective and multicentre cohort study in Brazil. Epidemiol Infect. 2020;148:e198. PMID: 32892789; https://doi.org/10.1017/S0950268820002034.

Kichloo A, Dettloff K, Aljadah M, et al. COVID-19 and hypercoagulability: a review. Clin Appl Thromb Hemost. 2020;26:1076029620962853. PMID: 33074732; https://doi.org/10.1177/1076029620962853.

Downloads

Published

2023-05-04

How to Cite

1.
Oliveira RMAF de, Gorzoni ML, Rosa RF. Mortality predictors in a cohort of patients with COVID-19 admitted to a large tertiary hospital in the city of São Paulo, Brazil. Sao Paulo Med J [Internet]. 2023 May 4 [cited 2025 Mar. 14];141(3):1-7. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/466

Issue

Section

Original Article